SCHEMBL4837689

SCHEMBL4837689

CCCCc1ccc(C(=O)Nc2cccc(C(=O)C=C3NC(C)(C)Cc4ccc(OC)cc43)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 2/20 0.43
MDH1 P40925 2/20 0.43
TRPV1 Q8NER1 2/20 0.43
NR1H4 Q96RI1 3/20 0.42
KCNA5 P22460 2/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
TP53 P04637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PLK3 Q9H4B4 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.40
NLRP3 Q96P20 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4837674 1.00 PLK1 (0.43) PLK1MDH1TRPV1NR1H4KCNA5
SCHEMBL4844194 0.98 PLK1 (0.46) PLK1MDH1TRPV1NR1H4KCNA5
SCHEMBL4844205 0.98 PLK1 (0.46) PLK1MDH1TRPV1NR1H4KCNA5
SCHEMBL4842404 0.97 PLK1 (0.47) PLK1MDH1TRPV1NR1H4KCNA5
SCHEMBL4842418 0.97 PLK1 (0.47) PLK1MDH1TRPV1NR1H4KCNA5
SCHEMBL4844026 0.95 ABCG2 (0.45) NR1H4KCNA5NPC1RAB9ATP53
SCHEMBL4844038 0.95 ABCG2 (0.45) NR1H4KCNA5NPC1RAB9ATP53
SCHEMBL4847141 0.92 NR1H4 (0.52) NR1H4NPC1RAB9ATP53ALDH1A1
SCHEMBL4847135 0.92 NR1H4 (0.52) NR1H4NPC1RAB9ATP53ALDH1A1
SCHEMBL4846022 0.92 NPC1 (0.44) KCNA5NPC1RAB9ATP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 PLK1 541/4885MDH1 1881/4885TRPV1 1672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.